NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
CHIATAI TIANQING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
02/25/2025
Trademark type
Combined
Nice classes
5
Filing date
03/27/2024
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Lianyungang, Jiangsu, CN
Examiner
BECKER, JOSEPH
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of two concentric circles, and the inner one is shaded. These circles are in a square. This design is to the left of four Chinese characters transliterated as "Zheng", "Da", "Tian" and "Qing". Under this wording is the smaller capitalized wording CHIATAI TIANQING.
Holders and representatives
Holders
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Representatives
Alexander Lazouski Lazouski IP LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical purposes for the treatment of cancer; Biochemical drugsbiochemical preparations for the treatment of cancer for medical purposes; Capsules sold empty for pharmaceuticals; Medicines for human purposes for the treatment of hepatopathyendocrine diseasemalnutritionurinary system diseasestumourrespiratory diseaseinfectious diseaseallergycardiovascular and cerebrovascular diseasesdiabetes; Vitamin tablets; Pharmaceutical preparations for pain relief; Active pharmaceutical ingredientnano-sized particles of paclitaxel sold as a component of pharmaceutical preparations for the treatment of cancer and skin diseases; Traditional Chinese medicines for human purpose for the treatment of respiratory system diseasesurinary system diseasesendocrine system diseasesnervous system diseasescardiovascular and cerebral system diseases and disorderskinematic system diseasestissue system diseases and digestive system diseases; Chemico-pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/19/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/19/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/19/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/15/2024
GNRT
NON-FINAL ACTION E-MAILED
10/15/2024
CNRT
NON-FINAL ACTION WRITTEN
10/15/2024
DOCK
ASSIGNED TO EXAMINER
10/07/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2024
NWAP
NEW APPLICATION ENTERED
03/27/2024
Continuous trademark protection
Get notified about every new filing that threatens CHIATAI TIANQING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.